Consumer Cases

Nationwide Opioid Epidemic Litigation

Robbins Geller serves on the Plaintiffs’ Executive Committee to spearhead more than 2,900 federal lawsuits brought on behalf of governmental entities and other plaintiffs in the sprawling litigation concerning the nationwide prescription opioid epidemic. In reporting on the selection of the lawyers to lead the case, The National Law Journal reported that “[t]he team reads like a ‘Who’s Who’ in mass torts.”

Apple Inc. Litigation

Robbins Geller serves on the Plaintiffs’ Executive Committee to advance judicial interests of efficiency and protect the interests of the proposed class in the Apple Inc. litigation. The case alleges Apple Inc. misrepresented its iPhone devices and the nature of updates to its mobile operating system (iOS), which allegedly included code that significantly reduced the performance of older-model iPhones and forced users to incur expenses replacing these devices or their batteries.

EpiPen Multidistrict Litigation

Robbins Geller serves as co-lead counsel in a case against Mylan Pharmaceuticals and Pfizer for engaging in crippling anti-competitive behavior that allowed the price of their ubiquitous and life-saving EpiPen auto-injector devices to rise over 600%, bilking American children and adults for hundreds of millions of dollars.

Zantac (Ranitidine) Products Liability Multi-District Litigation

Robbins Geller serves on the Plaintiffs’ Steering Committee to evaluate all economic loss, medical monitoring, and injury/wrongful death cases in the MDL, as well as to ensure that all group members’ interests and positions are represented in decision making. The nationwide case alleges that the heartburn medication Zantac, and specifically its active ingredient ranitidine, breaks down to form a carcinogen known as N-Nitrosodimethylamine (NDMA). 

Dolphin-Safe Tuna Litigation

After one year of investigation, Robbins Geller and its co-counsel filed four class-action lawsuits alleging that the three largest canned tuna companies in America, as well as Nestle Purina, falsely represented their tuna products as “Dolphin Safe” and from sustainably sourced tuna when, in fact, each of the companies utilize more cost-effective fishing techniques that indiscriminately kill or harm dolphins. The defendants are the owners of the Starkist® , Bumble Bee® , and Chicken of the Sea® brands of canned tuna, and Nestle Purina owns the Fancy Feast® brand of cat food. Each defendant is alleged to have violated the Racketeer Influenced and Corrupt Organizations Act (“RICO”) and state consumer protection statutes, as well as been unjustly enriched by their practices. For more information, click here.

Intel Corp. Litigation

Robbins Geller serves on the Plaintiffs’ Steering Committee in Intel, a massive multidistrict litigation pending in the United States District Court for the District of Oregon. Intel concerns serious security vulnerabilities – known as “Spectre” and “Meltdown” – that infect nearly all of Intel’s x86 processors manufactured and sold since 1995, the patching of which results in processing speed degradation of the impacted computer, server or mobile device.

Main Menu